NGL Fine-Chem Profit & Loss Annual

BSE: 524774 | NSE: NGLFINE | ISIN: INE887E01022 | Sector: Biotechnology & Drugs

1,795.00 +4.70 (0.26%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	338.69	278.08	317.50	257.97
Total Revenue	338.69	278.08	317.50	257.97
Costof Revenue Total	158.69	171.50	181.25	122.43
Gross Profit	180.00	106.58	136.26	135.55
Selling/ General/ Admin Expenses Total	45.12	66.01	63.70	53.74
Depreciation/ Amortization	11.64	11.29	10.37	8.33
Other Operating Expenses Total	81.62	6.25	4.72	2.06
Total Operating Expense	297.06	255.05	260.03	186.56
Operating Income	41.63	23.03	57.48	71.41
Interest Inc( Exp) Net- Non- Op Total	-13.38	24.39	34.03	49.24
Other Net	14.13	1.89	5.72	1.25
Net Income Before Taxes	54.42	27.36	66.60	77.59
Provisionfor Income Taxes	13.10	6.87	16.70	20.87
Net Income After Taxes	41.32	20.50	49.90	56.72
Net Income Before Extra Items	41.32	20.50	49.90	56.72
Net Income	41.32	20.50	49.90	56.72
Income Availableto Com Excl Extra Ord	41.32	20.50	49.90	56.72
Income Availableto Com Incl Extra Ord	41.32	20.50	49.90	56.72
Diluted Net Income	41.32	20.50	49.90	56.72
Diluted Weighted Average Shares	0.62	0.62	0.62	0.62
Diluted EPS Excluding Extra Ord Items	66.88	33.18	80.77	91.81
DPS- Common Stock Primary Issue	1.75	1.75	1.75	1.75
Diluted Normalized EPS	66.88	33.18	80.77	91.81